ID
40952
Descripción
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Palabras clave
Versiones (2)
- 24/4/20 24/4/20 -
- 7/6/20 7/6/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
7 de junio de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
Investigational product (Liver), Liver Event 3-DF
- StudyEvent: ODM
Descripción
If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.
Alias
- UMLS CUI-1
- C0023884
- UMLS CUI-2
- C0877248
- UMLS CUI-3
- C0231290
- UMLS CUI-4
- C4688482
Descripción
Start Date Investigational Product
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C4688482
Descripción
Start Date Investigational Product not applicable
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C4688482
- UMLS CUI [1,3]
- C1272460
Descripción
End Date Investigational Product
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C4688482
- UMLS CUI [1,2]
- C0806020
Descripción
End Date Investigational Product not applicable
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C4688482
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [1,3]
- C1272460
Similar models
Investigational product (Liver), Liver Event 3-DF
- StudyEvent: ODM
C0877248 (UMLS CUI-2)
C2709058 (UMLS CUI-3)
C4688482 (UMLS CUI-4)
C4688482 (UMLS CUI [1,2])
C4688482 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
C0877248 (UMLS CUI-2)
C0231290 (UMLS CUI-3)
C4688482 (UMLS CUI-4)
C4688482 (UMLS CUI [1,2])
C4688482 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])